 |
TSO3: Conference Call and Webcast - Financial Results for Q2 2008July 17, 2008Quebec City, Quebec, Canada, July 17, 2008 – TSO3 Inc. (“TSO3”) (TSX: TOS) today announced that it will report financial results for the second quarter 2008 ended June 30, 2008, on Friday, August 1, 2008. TSO3 will host a Conference Call at 11:00 A.M. (ET), on August 1, 2008.Analysts and institutional investors are invited to participate. The numbers to dial for access are 514 807-8791 (Montréal area), (416) 644-3416 (Toronto area) or the toll-free number 1 800 732-9303. Journalists and other interested parties may listen to the live Webcast of the Conference Call accessible via TSO3's Website at: www.tso3.com. The Webcast will be archived for 90 days. As previously announced, from now on, the sales realized by the Company during the normal course of its operations will be disclosed within the quarterly results report. About TSO3 TSO3, founded in Québec City in 1998, specializes in the research and development of innovative, high-performance medical instrument sterilization technology with high commercial potential. The Company’s first product, the 125L Ozone Sterilizer, is designed for sterile processing centers in the hospital environment. In contrast to other methods used, the ozone sterilization process developed and patented by TSO3 meets all standards required by the evolution in sterilization needs, which are: significant costs savings, increased safety for patients and hospital staff, and a “green” environmentally safe process. The Company believes that its technology represents an advantageous replacement solution to other low temperature sterilization processes currently used in hospitals. The 125L Ozone Sterilizer is cleared for commercialization by the US Food and Drug Administration and by Health Canada. TSO3 is in commercialization phase for this first product since 2006. For more information about TSO3, visit the Company’s Web site at www.tso3.com The statements in this release and oral statements made by representatives of TSO3 relating to matters that are not historical facts (including, without limitation, those regarding the timing or outcome of any financing undertaken by TSO3) are forward-looking statements that involve certain risks, uncertainties and hypotheses, including, but not limited to, general business and economic conditions, the condition of the financial markets, the ability of TSO3 to obtain financing on favourable terms and other risks and uncertainties. The TSX has neither approved nor disapproved the information contained herein and accepts no responsibility for it. - 30 - Source: TSO3 Inc. Information: Marc Boisjoli CFO (418) 651-0003, ext. 228 mboisjoli@tso3.com Frédéric Tremblay HKDP Tel.: 514 395-0375, ext. 234 |
© 2005-2008 TSO3. All Rights Reserved.
